(Q38419898)

2 September 2017

title

Clinical and pathological characterization of endometrial cancer in young women: identification of a cohort without classical risk factors (English)

1 reference

2 September 2017

1 reference

2

Aline Talhouk

1 reference

2 September 2017

3

C Blake Gilks

1 reference

2 September 2017

Angela Burleigh

1

1 reference

2 September 2017

Jessica N McAlpine

series ordinal

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

12 April 2015

1 reference

2 September 2017

1 reference

2 September 2017

volume

138

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

141-146

1 reference

Endometrial carcinoma in women aged 40 years and younger

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Testing women with endometrial cancer to detect Lynch syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Adipose tissue distribution in postmenopausal women with adenomatous hyperplasia of the endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Endometrial carcinoma; ovarian dysfunction--a risk factor in young women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Endometrial cancer and venous thromboembolism in women under age 50 who take tamoxifen for prevention of breast cancer: a systematic review.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Circulating levels of sex steroid hormones and risk of endometrial cancer in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Interpretation of Genetic Test Results for Hereditary Nonpolyposis Colorectal Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

From endometrial hyperplasia to endometrial cancer: insight into the biology and possible medical preventive measures.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Polycystic ovary syndrome and endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Molecular pathogenesis of endometrial cancers in patients with Lynch syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

The role of surgery in endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Conservative treatment of early endometrial cancer: preliminary results of a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Oncologic and reproductive outcomes with progestin therapy in women with endometrial hyperplasia and grade 1 adenocarcinoma: a systematic review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Prognostic factors of oncologic and reproductive outcomes in fertility-sparing management of endometrial atypical hyperplasia and adenocarcinoma: systematic review and meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Impact of obesity on the results of fertility-sparing management for atypical hyperplasia and grade 1 endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Endometrial cancer: a review and current management strategies: part II.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Risk factors for young premenopausal women with endometrial cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Retrospective analysis on coexisting ovarian cancer in 976 patients with clinical stage I endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Synchronous primary cancers of the endometrium and ovary in young women: a Korean Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Menstrual and reproductive factors and endometrial cancer risk: Results from a population-based case-control study in urban Shanghai

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Mismatch repair protein expression in 1049 endometrial carcinomas, associations with body mass index, and other clinicopathologic variables.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Prevalence of Lynch syndrome among patients with newly diagnosed endometrial cancers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Prospective Determination of Prevalence of Lynch Syndrome in Young Women With Endometrial Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Integrated genomic characterization of endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Polymerase ɛ (POLE) mutations in endometrial cancer: clinical outcomes and implications for Lynch syndrome testing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Microsatellite instability and hMLH1/hMSH2 expression in young endometrial carcinoma patients: associations with family history and histopathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Microsatellite Instability and Epigenetic Inactivation ofMLH1and Outcome of Patients With Endometrial Carcinomas of the Endometrioid Type

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Pathologic features of endometrial carcinoma associated with HNPCC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Reproductive factors and risk of endometrial cancer. The Iowa Women's Health Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

An aggregated analysis of hormonal factors and endometrial cancer risk by parity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2015.02.028

10.1016/J.YGYNO.2015.02.028

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference